| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |